Enzo Biochem (ENZ) reported Q4 EPS of (17c)

Enzo Biochem (NYSE: ENZ) reported Q4 EPS of ($0.17). Revenue for the quarter came in at $20.28 million.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Lowe's slashes full-year sales outlook amid DIY spending pressure
• ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c